Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| University of Manchester, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| University of Manchester, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| University of Manchester, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| University of Manchester, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| University of Manchester, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| University of Manchester, Pharmaceuticals &Healthcare, Deal Details | 11 | 22 |
| Partnerships | 11 | 1 |
| Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies | 11 | 2 |
| OptiBiotix Health and University of Manchester Form Joint Venture | 13 | 1 |
| AstraZeneca Enters into Co-Development Agreement with University of Manchestery | 14 | 1 |
| MedImmune Enters into Research Agreement with University of Manchester | 15 | 1 |
| MedImmune Enters into Research Agreement with COEBP | 16 | 1 |
| AstraZeneca Forms Joint Venture with University of Manchester | 17 | 1 |
| Johnson &Johnson Enters into Co-Development Agreement with University of Manchester | 18 | 1 |
| Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents | 19 | 1 |
| GlaxoSmithKline Enters Into Agreement With Cancer Research Technology And University of Manchester For Cancer Drugs | 20 | 2 |
| Autifony Therapeutics Enters Into Agreement With Universities Of Manchester And Newcastle To Develop Treatment For Schizophrenia | 22 | 1 |
| Cancer Research Technology, University of Manchester And AstraZeneca Enters Into Agreement To Develop Cancer Drugs | 23 | 2 |
| Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool | 25 | 1 |
| GlaxoSmithKline, AstraZeneca And The University Of Manchester Form Joint Venture | 26 | 2 |
| Licensing Agreements | 28 | 1 |
| Acucela Enters into Licensing Agreement with University of Manchester | 28 | 1 |
| Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors | 29 | 2 |
| Curapel Enters into Licensing Agreement with University of Manchester | 31 | 1 |
| Asset Transactions | 32 | 1 |
| OptiBiotix Health Acquires Rights to Skin Health Intellectual Property from University of Manchester | 32 | 1 |
| University of Manchester - Key Competitors | 33 | 1 |
| Key Employees | 34 | 1 |
| Locations And Subsidiaries | 35 | 1 |
| Head Office | 35 | 1 |
| Other Locations &Subsidiaries | 35 | 1 |
| Appendix | 36 | 1 |
| Methodology | 36 | 1 |
| About GlobalData | 36 | 1 |
| Contact Us | 36 | 1 |
| Disclaimer | 36 | 1 |